Lorenza Rimassa

Humanitas University

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (14)

Mahvish Muzaffar

East Carolina University

UNITED STATES

View details

Armando Santoro

Professore

Humanitas University

ITALY

View details

ciro franzese

Assistant Professor

Humanitas University

ITALY

View details

Ferran Torres

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Najib Ben Khaled

GERMANY

View details

Bruno Sangro

SPAIN

View details

Maria Reig

Head of the Liver Oncology group-CIBER

SPAIN

View details

Alessio Cortellini

Imperial College London

UNITED KINGDOM

View details

Margherita Rimini

ITALY

View details

Enrico N De Toni

University Hospital

GERMANY

View details

Giuseppe Cabibbo

University of Palermo

ITALY

View details

Guido Costa

Adjunct Professor

Humanitas University

ITALY

View details

Andrea Casadei-Gardini

ITALY

View details

Antonio D'Alessio

Imperial College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lorenza Rimassa

Research Interests

Explore related searches

Contact this professor

Articles (21)

Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma

Navigating the Landscape of Liver Cancer Management: Study Designs in Clinical Trials and Clinical Practices

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population

New systemic treatment options for advanced cholangiocarcinoma

Multicenter phase I/II trial of gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer

Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment

Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction

CT-based radiogenomics of intrahepatic cholangiocarcinoma

The tumor microenvironment of VETC+ hepatocellular carcinoma is enriched of immunosuppressive TAMs spatially close to endothelial cells

Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study

Network meta-analysis: A map to navigate the maze of treatment for advanced hepatocellular carcinoma

Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study).

Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing?

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data.

Identification of Atezolizumab Plus Bevacizumab Prognostic Index <i>via</i> Recursive Partitioning Analysis in HCC: The ABE Index.

Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?

Combination immunotherapy for hepatocellular carcinoma

The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment

Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry

Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights

Collaborators (14)

Mahvish Muzaffar

Armando Santoro

ciro franzese

Ferran Torres

Najib Ben Khaled

Bruno Sangro

Maria Reig

Alessio Cortellini

Margherita Rimini

Enrico N De Toni

Giuseppe Cabibbo

Guido Costa

Andrea Casadei-Gardini

Antonio D'Alessio

Make your next move.